IBRX vs AAPL: Which Stock is Better?
Side-by-side comparison of Immunitybio Inc and Apple Inc in 2026
IBRX
Immunitybio Inc
$8.11
AAPL
Apple Inc
$325.13
Key Metrics Comparison
| Metric | IBRX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $7.88B | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | IBRX |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 425.1% | 7.9% | IBRX |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze IBRX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBRX or AAPL a better investment?
Comparing IBRX and AAPL: Immunitybio Inc has a market cap of $7.88B while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBRX and AAPL?
IBRX (Immunitybio Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBRX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBRX or AAPL?
IBRX has higher revenue growth at 425.1% vs 7.9% for AAPL.
Which company is more profitable: IBRX or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for IBRX.
Which is the larger company: IBRX or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $7.88B for IBRX.
Should I buy IBRX or AAPL in 2026?
Both IBRX and AAPL have investment merit. IBRX trades at $8.11 while AAPL trades at $325.13. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBRX and AAPL stock?
Key differences: Market Cap ($7.88B vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (425.1% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy IBRX or AAPL in 2026?
The choice between IBRX and AAPL depends on your investment goals. IBRX shows higher revenue growth (425.1%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between IBRX and AAPL?
IBRX (Immunitybio Inc) has a market cap of $7.88B, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.